Results 301 to 310 of about 488,068 (360)

Metformin in non-diabetic patients with autosomal dominant polycystic kidney disease: a systematic review and meta-analysis of randomized controlled trials. [PDF]

BMC Nephrol
Almeida V, Maciel L, Valverde Ramos AB, Sousa C, Ferraz M, Afonso L, Dibo P, Nunes I.   +7 more
europepmc   +1 more source

Pain Management in Autosomal Dominant Polycystic Kidney Disease: Clinical Challenges and a Stepwise Algorithmic Approach. [PDF]

Kidney360
Borghol AH, Munairdjy Debeh FG, Ghanem A, Bou Antoun MT, Rangarajan V, Mina J, Hassanein M, Baker LW, Gupta S, Mao SA, Hunt CL, Hogan MC, Mao MA, Chebib FT.   +13 more
europepmc   +1 more source

A cross model spatial and single-cell atlas reveals the conserved involvement of osteopontin in polycystic kidney disease

Miller SJ, Zhong H, Wu W, Cordova AM, Smith ME, Yashchenko A, Li Z, Jafree DJ, Zimmerman CN, DeVette CI, Do V, Hignite M, Darby IG, Ahmed KB, Park Y, Nusrat F, Maryam B, Lu S, Li X, Gipson JR, Li X, Long DA, Weiser-Evans M, Yoder BK, Cowley BD, Hopp K, Stubbs J, Ma Q, Ma A, Zimmerman KA.   +29 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy.

American Journal of Kidney Diseases, 2021
Autosomal Dominant Polycystic Kidney Disease is the most common inherited cause of kidney failure accounting for 5-10% of cases. Predicting which patient would progress rapidly to kidney failure is critical to assess the risk-benefit ratio of any ...
F. Chebib, V. Torres
semanticscholar   +1 more source

Prescribed Water Intake in Autosomal Dominant Polycystic Kidney Disease

NEJM Evidence, 2021
Prescribed Water Intake in Autosomal Dominant Polycystic Kidney Disease The effect of increased water intake on kidney cyst growth in patients with polycystic kidney disease was compared for two groups randomly assigned to either prescribed or ad libitum
Gopi K Rangan, Annette Wong, A. Munt, Jennifer Zhang, S. Saravanabavan, Margaret Allman-Farinelli, S. Badve, Neil Boudville, Bradley J. Erickson, Mangalee R. Fernando, Sheryl L. Foster, Adriana Gregory, I. Haloob, Carmel M. Hawley, David W. Johnson, Timothy L. Kline, Vincent W. Lee, Maureen A. Lonergan, Elaine Pascoe, A. Rangan, Simon D Roger, Kamal Sud, Vicente E. Torres, Sundareswari V. Adinarayanan, D. Harris   +24 more
semanticscholar   +1 more source

Polycystic Kidney/Liver Disease

Clinics in Liver Disease, 2022
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder that leads to chronic kidney disease and end-stage kidney disease (ESKD). Polycystic liver disease (PCLD) is the most common extrarenal manifestation of ADPKD. Though isolated PCLD and PCLD due to ADPKD are genetically distinct, they follow a similar clinical course of ...
Rebecca, Roediger, Douglas, Dieterich, Pramodh, Chanumolu, Priya, Deshpande   +3 more
openaire   +2 more sources

Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease

Science Translational Medicine, 2020
Pharmacological induction of NRF2 restores redox homeostasis and slows cystogenesis in mouse models of polycystic kidney disease. Antioxidants dominate ADPKD Autosomal dominant polycystic kidney disease (ADPKD) is a relatively common genetic disorder ...
Yi Lu, Yongzhan Sun, Zhiheng Liu, Yumei Lu, Xu Zhu, Bingxue Lan, Zeyun Mi, Lin Dang, Na Li, Wen-hu Zhan, Lu Tan, J. Pi, H. Xiong, Lirong Zhang, Yupeng Chen   +14 more
semanticscholar   +1 more source